Valomaciclovir

DB06575InvestigationalSmall molecule

Investigated for use/treatment in herpes zoster infections and viral infection.

Chemical structure of Valomaciclovir
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in herpes zoster infections and viral infection.Curator reviewed
Formula / weight
C15H24N6O4 · 352.395 g/mol (avg)
Code names
EPB-348

Resolves to

Compound
UNIIF094Y61748CAS195157-34-7ChEMBLCHEMBL2107301
Structure
InChIKeyATSZELKUSAREPW-ZJUUUORDSA-NSMILESCC(C)[C@H](N)C(=O)OCC[C@@H](CO)CN1C=NC2=C1N=C(N)NC2=O
Targets
Q91CQ6DNApol

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
370Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Valomaciclovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In